Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.19 EUR
104.37 M EUR
9.82 B EUR
1.71 B
About ASTELLAS PHARMA
Sector
CEO
Naoki Okamura
Headquarters
Tokyo
Website
Founded
1923
ISIN
JP3942400007
FIGI
BBG000BL2HB8
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of YPH is 9.73 EUR — it has decreased by −0.49% in the past 24 hours. Watch ASTELLAS PHARMA INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange ASTELLAS PHARMA INC stocks are traded under the ticker YPH.
YPH stock has risen by 1.65% compared to the previous week, the month change is a −9.04% fall, over the last year ASTELLAS PHARMA INC has showed a −13.66% decrease.
We've gathered analysts' opinions on ASTELLAS PHARMA INC future price: according to them, YPH price has a max estimate of 14.84 EUR and a min estimate of 8.65 EUR. Watch YPH chart and read a more detailed ASTELLAS PHARMA INC stock forecast: see what analysts think of ASTELLAS PHARMA INC and suggest that you do with its stocks.
YPH stock is 2.04% volatile and has beta coefficient of 0.33. Track ASTELLAS PHARMA INC stock price on the chart and check out the list of the most volatile stocks — is ASTELLAS PHARMA INC there?
Today ASTELLAS PHARMA INC has the market capitalization of 17.54 B, it has decreased by −5.36% over the last week.
Yes, you can track ASTELLAS PHARMA INC financials in yearly and quarterly reports right on TradingView.
ASTELLAS PHARMA INC is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
YPH earnings for the last quarter are 0.13 EUR per share, whereas the estimation was 0.11 EUR resulting in a 11.36% surprise. The estimated earnings for the next quarter are 0.12 EUR per share. See more details about ASTELLAS PHARMA INC earnings.
ASTELLAS PHARMA INC revenue for the last quarter amounts to 2.89 B EUR, despite the estimated figure of 2.67 B EUR. In the next quarter, revenue is expected to reach 2.78 B EUR.
YPH net income for the last quarter is 224.37 M EUR, while the quarter before that showed 218.08 M EUR of net income which accounts for 2.88% change. Track more ASTELLAS PHARMA INC financial stats to get the full picture.
ASTELLAS PHARMA INC dividend yield was 4.26% in 2023, and payout ratio reached 736.46%. The year before the numbers were 3.19% and 110.62% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 29, 2024, the company has 14.75 K employees. See our rating of the largest employees — is ASTELLAS PHARMA INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ASTELLAS PHARMA INC EBITDA is 2.42 B EUR, and current EBITDA margin is 20.95%. See more stats in ASTELLAS PHARMA INC financial statements.
Like other stocks, YPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ASTELLAS PHARMA INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ASTELLAS PHARMA INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ASTELLAS PHARMA INC stock shows the strong sell signal. See more of ASTELLAS PHARMA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.